Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort.

MLA

Kobayashi, Masatake, et al. “Proteomic Profiles of Left Atrial Volume and Its Influence on Response to Spironolactone: Findings from the HOMAGE Trial and STANISLAS Cohort.” European Journal of Heart Failure, vol. 26, no. 5, May 2024, pp. 1231–41. EBSCOhost, https://doi.org/10.1002/ejhf.3202.

APA

Kobayashi, M., Ferreira, J. P., Duarte, K., Bresso, E., Huttin, O., Bozec, E., Brunner La Rocca, H., Delles, C., Clark, A. L., Edelmann, F., González, A., Heymans, S., Pellicori, P., Petutschnigg, J., Verdonschot, J. A. J., Rossignol, P., Cleland, J. G. F., Zannad, F., & Girerd, N. (2024). Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort. European Journal of Heart Failure, 26(5), 1231–1241. https://doi.org/10.1002/ejhf.3202

Chicago

Kobayashi, Masatake, João Pedro Ferreira, Kevin Duarte, Emmanuel Bresso, Olivier Huttin, Erwan Bozec, Hans‐Peter Brunner La Rocca, et al. 2024. “Proteomic Profiles of Left Atrial Volume and Its Influence on Response to Spironolactone: Findings from the HOMAGE Trial and STANISLAS Cohort.” European Journal of Heart Failure 26 (5): 1231–41. doi:10.1002/ejhf.3202.